Bifiform capsule, # 30

• diarrhea caused by acute and exacerbation of chronic gastroenteritis, rotavirus infection;

• antibiotic-associated diarrhea;

• traveler's diarrhea;

• in the complex therapy of acute intestinal infections;

• in the complex therapy of chronic diseases of the gastrointestinal tract, such as colitis, irritable bowel syndrome and other gastrointestinal disorders of functional genesis;

• normalization of intestinal microflora, treatment and prevention of dysbacteriosis and maintenance of the immune system in children over 2 years of age and adults;

• lactose intolerance;

• as part of a comprehensive standard eradication therapy in patients with Helicobacter pylori infection.

In case of acute diarrhea, the drug must be taken 1 capsule 4 times a day until the stool is normalized. Then taking the drug should be continued at a dose of 2-3 capsules per day until the symptoms disappear completely.

To normalize the intestinal microflora and support the immune system, the drug is prescribed in a dose of 2-3 capsules per day for 10-21 days.

Patients with lactose intolerance are advised to take the drug 1 capsule 3 times a day.

When carrying out eradication therapy, Bifiform is prescribed 2 capsules 2 times a day for two weeks from the first day of eradication therapy.

Children from 2 years old take 1 capsule 2-3 times a day. If the child cannot swallow the capsule, it must be opened and the contents mixed with a small amount of liquid.

1 enteric capsule contains:
Active substances : Enterococcus faecium 1 x 107 CFU Bifidobacterium longum 1 x 107 CFU
Excipients:

Dextrose, yeast starter, locust bean gum, magnesium

stearate, lactulose.

The composition of the capsule shell:

Gelatin, methacrylic acid and methyl methacrylate copolymer [1: 1], methacrylic acid and ethyl acrylate copolymer [1: 1] [30% dispersion], talc, macrogol-6000, soybean oil, diacetylated glycerides, titanium dioxide.

Individual hypersensitivity to the components of the drug.

Children under 2 years of age.

Trade name: BIFIFORM

Grouping name: Bifidobacterium longum + Enterococcus fetium

Dosage form:

enteric capsules

Composition:

1 enteric capsule contains:
Active substances : Enterococcus faecium 1 x 107 CFU Bifidobacterium longum 1 x 107 CFU
Excipients:

Dextrose, yeast starter, locust bean gum, magnesium

stearate, lactulose.

The composition of the capsule shell:

Gelatin, methacrylic acid and methyl methacrylate copolymer [1: 1], methacrylic acid and ethyl acrylate copolymer [1: 1] [30% dispersion], talc, macrogol-6000, soybean oil, diacetylated glycerides, titanium dioxide.

Description

White hard gelatin capsules number 3. The content of the capsule is a powder of light yellow with a gray shade.

Pharmacotherapeutic group

Eubiotic.

ATX code: A07FA

Indications for use

• diarrhea caused by acute and exacerbation of chronic gastroenteritis, rotavirus infection;

• antibiotic-associated diarrhea;

• traveler's diarrhea;

• in the complex therapy of acute intestinal infections;

• in the complex therapy of chronic diseases of the gastrointestinal tract, such as colitis, irritable bowel syndrome and other gastrointestinal disorders of functional genesis;

• normalization of intestinal microflora, treatment and prevention of dysbacteriosis and maintenance of the immune system in children over 2 years of age and adults;

• lactose intolerance;

• as part of a comprehensive standard eradication therapy in patients with Helicobacter pylori infection.

Contraindications

Individual hypersensitivity to the components of the drug.

Children under 2 years of age.

Application during pregnancy and during breastfeeding

The use of the drug Bifiform during pregnancy and lactation is considered safe, since the drug is not absorbed and does not have a systemic effect.

Method of administration and dosage

In case of acute diarrhea, the drug must be taken 1 capsule 4 times a day until the stool is normalized. Then taking the drug should be continued at a dose of 2-3 capsules per day until the symptoms disappear completely.

To normalize the intestinal microflora and support the immune system, the drug is prescribed in a dose of 2-3 capsules per day for 10-21 days.

Patients with lactose intolerance are advised to take the drug 1 capsule 3 times a day.

When carrying out eradication therapy, Bifiform is prescribed 2 capsules 2 times a day for two weeks from the first day of eradication therapy.

Children from 2 years old take 1 capsule 2-3 times a day. If the child cannot swallow the capsule, it must be opened and the contents mixed with a small amount of liquid.

Side effect

When used in recommended doses for established indications, side effects have not been identified.

Overdose

Overdose symptoms have not been previously reported. If the recommended doses are significantly exceeded, medical supervision is advisable.

Interaction with other medicinal products

The drug can be used in combination with other drugs. Simultaneous administration with antibiotics is allowed.

special instructions

The drug does not affect the ability to drive a car and use mechanisms.
Precautions: Do not exceed the maximum daily dose.

Release form

Enteric capsules. 20, 30 or 40 capsules in an aluminum case, sealed with a polyethylene stopper with a first opening control, containing a desiccant. 1 pencil case with instructions for use is placed in a cardboard box.

Transportation

At a temperature not higher than 25 ? C.

Storage conditions

In a dry place at a temperature not exceeding 25 ? C. Keep out of the reach of children.

Shelf life

2 years. Do not use after the expiration date printed on the package.

Conditions of dispensing from pharmacies

Without recipe.